All 28 OZEM (ROUNDHILL GLP-1 & WEIGHT LOSS ETF) Holdings
There are 28 OZEM holdings. Top 10 companies weight: 67.35%.
Total Market Cap: $1.75T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (28 stocks) | +29.13% | 23.40 | 18.65 | 0.21 | +15.15% | +25.86% | 0.69 | ||||||||||
1 | LLY | Eli Lilly And Co | 17.23% | $1,065.12 | $970B | Drug Manufacturers - General | Healthcare | +29.14% | 45.43 | 29.85 | 0.18 | N/A | N/A | 71 | +14.08% | $1.22K | +40.67% | 0.71 |
2 | NVO | Novo Nordisk As Adr | 13.52% | $42.92 | $198B | Drug Manufacturers - General | Healthcare | +24.26% | 10.39 | 13.07 | 0.39 | N/A | N/A | 60 | +9.23% | $47 | +3.64% | 0.96 |
3 | PFE | Pfizer Inc | 6.57% | $25.55 | $149B | Drug Manufacturers - General | Healthcare | -6.35% | 12.31 | 8.73 | 0.09 | N/A | N/A | 56 | +14.25% | $29 | -3.24% | 0.40 |
4 | n/a | Cspc Pharmaceutical Group Ltd | 4.83% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
5 | n/a | Chugai Pharmaceutical Co Ltd | 4.54% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | VKTX | Viking Therapeutics Inc | 4.46% | $29.29 | $3.67B | Biotechnology | Healthcare | +47.58% | N/A | N/A | N/A | N/A | N/A | 78 | +216.08% | $93 | +40.92% | 1.57 |
7 | n/a | Zealand Pharma As | 4.22% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
8 | n/a | Innovent Biologics Inc | 4.09% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | KLRA | Kailera Therapeutics Inc | 4.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
10 | n/a | Ascletis Pharma Inc Ordinary Shares | 3.88% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
11 | n/a | Hanmi Pharm Co Ltd | 3.76% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
12 | AMGN | Amgen Inc | 3.61% | $328.26 | $181B | Drug Manufacturers - General | Healthcare | +3.49% | 23.21 | 14.79 | 0.75 | N/A | N/A | 60 | +7.30% | $352 | +10.27% | 0.48 |
13 | AZN:XLON | Astrazeneca Plc | 3.45% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
14 | n/a | Roche Holding Ag Ordinary Shares New | 2.95% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
15 | REGN | Regeneron Pharmaceuticals Inc | 2.66% | $602.92 | $65B | Biotechnology | Healthcare | +20.31% | 14.98 | 13.39 | 83.17 | N/A | N/A | 72 | +38.21% | $833 | +3.75% | 0.64 |
16 | n/a | United Laboratories International Holdings Ltd | 2.60% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
17 | GPCR | Structure Therapeutics Inc Adr | 2.50% | $37.19 | $2.81B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +186.29% | $106 | 0.00% | 0.89 |
18 | MBX | Mbx Biosciences Inc | 2.15% | $30.70 | $1.52B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +125.05% | $69 | 0.00% | 1.46 |
19 | n/a | Gubra As | 2.14% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
20 | GILD | Gilead Sciences Inc | 1.75% | $127.57 | $166B | Drug Manufacturers - General | Healthcare | +98.59% | 18.01 | 15.22 | 0.33 | N/A | N/A | N/A | N/A | N/A | +18.23% | N/A |
21 | RYTM | Rhythm Pharmaceuticals Inc | 1.54% | $84.35 | $6.26B | Biotechnology | Healthcare | +17.00% | N/A | N/A | N/A | N/A | N/A | 79 | +63.84% | $138 | +35.04% | 0.94 |
22 | BHVN | Biohaven Ltd | 1.48% | $10.12 | $1.70B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 73 | +114.53% | $22 | 0.00% | 1.53 |
23 | n/a | Shionogi & Co Ltd | 1.27% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
24 | WVE | Wave Life Sciences Ltd | 0.80% | $5.69 | $1.22B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +285.59% | $22 | -3.81% | 1.46 |
25 | FGXXX | First American Government Obligs X | 0.59% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
26 | CRBP | Corbus Pharmaceuticals Holdings Inc | 0.32% | $7.54 | $173M | Biotechnology | Healthcare | -33.12% | N/A | N/A | N/A | N/A | N/A | 77 | +384.08% | $37 | -34.15% | 1.20 |
27 | n/a | Other Assets And Liabilities | -0.36% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | n/a | Swiss Franc | -0.58% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
OZEM (ROUNDHILL GLP-1 & WEIGHT LOSS ETF) Sector Allocation
HEALTHCARE
48.30%MATERIALS
3.50%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%